mTORC2

Edit links
Source: Wikipedia, the free encyclopedia.
(Redirected from
Mechanistic target of rapamycin complex 2
)
Chr. 1 p36
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 5 p13.1
Chr. 16 p13.3
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 9 q34.11
Search for
StructuresSwiss-model
DomainsInterPro

mTOR Complex 2 (mTORC2) is an acutely rapamycin-insensitive protein complex formed by serine/threonine kinase mTOR that regulates cell proliferation and survival, cell migration and cytoskeletal remodeling.[1] The complex itself is rather large, consisting of seven protein subunits. The catalytic mTOR subunit, DEP domain containing mTOR-interacting protein (DEPTOR), mammalian lethal with sec-13 protein 8 (mLST8, also known as GβL), and TTI1/TEL2 complex are shared by both mTORC2 and mTORC1. Rapamycin-insensitive companion of mTOR (RICTOR), mammalian stress-activated protein kinase interacting protein 1 (mSIN1), and protein observed with rictor 1 and 2 (Protor1/2) can only be found in mTORC2.[2][3] Rictor has been shown to be the scaffold protein for substrate binding to mTORC2.[4]

Function

Though less understood than mTORC1, mTORC2 has been shown to respond to growth factors and to modulate cell metabolism and cell survival, thanks to its activation of the survival kinase

RhoA, Rac1, Cdc42, and protein kinase C α (PKCα).[7]

mTORC2 also regulates cellular proliferation and metabolism, in part through the regulation of

macroautophagy[13] and chaperone-mediated autophagy).[14] In addition, mTORC2 has tyrosine kinase activity and phosphorylates IGF-IR and insulin receptor at the tyrosine residues Y1131/1136 and Y1146/1151, respectively, leading to full activation of IGF-IR and InsR.[15]

The precise localization of mTORC2 inside cells is still unclear. Some findings based on its activity point to cellular endomembranes, such as of mitochondria, as a possible site of mTORC2,[6] whereas other suggest that the complex could be additionally located at the plasma membrane; however, this may be due to its association with Akt.[16] It is not clear if these membranes display mTORC2 activity in the cellular context, or if these pools contribute to phosphorylation of mTORC2 substrates.[17]

In neurons, mTORC2 facilitates actin polymerization.[18] Mice with reduced mTORC2 have deficient synaptic plasticity and memory.[18]

Regulation and signaling

mTORC2 appears to be regulated by insulin, growth factors, and serum.[19] In contrast to TORC1, which is mainly stimulated by nutrients, TORC2 is mainly stimulated by growth factors.[20] Originally, mTORC2 was identified as a rapamycin-insensitive entity, as acute exposure to rapamycin did not affect mTORC2 activity or Akt phosphorylation.[8] However, subsequent studies have shown that, at least in some cell lines, chronic exposure to rapamycin, while not affecting pre-existing mTORC2s, promotes rapamycin inhibition of free mTOR molecules, thus inhibiting the formation of new mTORC2.[21] mTORC2 can be inhibited by chronic treatment with rapamycin in vivo, both in cancer cells and normal tissues such as the liver and adipose tissue.[22][23] Torin-1 can also be used to inhibit mTORC2.[13][24]

Upstream signaling

Similar to other PI3K regulated proteins, mTORC2 has a mSin1 subunit, which contains a phosphoinositide-binding

PIP3 at the plasma membrane. mSin1 subunit can also be phosphorylated by Akt. This indicates the existence of a positive feedback loop in which partial activation of Akt stimulates the activation of mTORC2. The complex then phosphorylates and fully activates Akt.[1][25][26]

What might come as a surprise is that mTORC2 signaling is also regulated by mTORC1. This is due to the presence of a negative feedback loop between mTORC1 and insulin/PI3K signaling. Grb10, a negative regulator of insulin/IGF-1 receptor signaling upstream of Akt and mTORC2, is phosphorylated and therefore activated by mTORC1.[27] Additionally, some components of G protein signalling has been revealed as important regulators of mTORC2 activity as Ric-8B protein and some lipid metabolites.[28][29][30]

Downstream signaling

mTORC2 controls cell survival and proliferation mainly through phosphorylation of several members of the AGC (

HDACs.[36][12]

Role in disease

Since mTORC2 plays a crucial role in metabolic regulation, it can be linked to many human pathologies. Deregulation of mTOR signaling, including mTORC2, affects transduction of insulin signal and therefore can disrupt its biological functions and lead to metabolic disorders, such as type 2 diabetes mellitus.[37] In many types of human cancer, hyperactivation of mTORC2 caused by mutations and aberrant amplifications of mTORC2 core components is frequently observed.[38] On metabolic level, activation of mTORC2 stimulates processes related to alteration of glucose metabolism in cancer cells, altogether known as Warburg effect.[39] mTORC2-mediated lipogenesis has been linked to promotion of hepatocellular carcinoma through stimulation of glycerophospholipid and sphingolipid synthesis.[40]

Although mTORC2 is acutely insensitive to

glucose intolerance.[1][41][12] By contrast, dietary administration of Torin1, a dual mTORC1/2 inhibitor, resulted in prolonged lifespan in D. melanogaster with no reduction in fertility [42] and Akt haploinsufficiency, an mTORC2 downstream target, extended lifespan in mice.[43]

The mTORC2 pathways plays a crucial role in pathogenesis of

lung fibrosis, and inhibitors of its active site such as sapanisertib (MLN-0128) have potential in the treatment of this disease and similar fibrotic lung diseases.[44]

Chronic mTORC2 activity may play a role in

systemic lupus erythematosus by impairing lysosome function.[45]

Studies using mice with tissue-specific loss of Rictor, and thus inactive mTORC2, have found that mTORC2 plays a critical role in the regulation of

pancreatic beta cells results in reduced beta cell mass and insulin secretion, and hyperglycemia and glucose intolerance.[56] mTORC2 activity in the hypothalamus of mice increases with age, and deletion of Rictor in hypothalamic neurons promotes obesity, frailty, and shorter lifespan in mice.[57]

References

  1. ^
    PMID 28283069
    .
  2. PMID 22500797
    .
  3. PMID 29567957
    .
  4. PMID 21531565
    .
  5. PMID 25242279
    .
  6. ^
    PMID 23852728
    .
  7. S2CID 4658268
    .
  8. ^
    S2CID 45837814
    .
  9. PMID 9445477
    .
  10. S2CID 25454463
    .
  11. PMID 20034776
    .
  12. ^
    PMID 34250734
    .
  13. ^
    PMID 24606695
    .
  14. PMID 26118642
    .
  15. PMID 26584640
    .
  16. PMID 21157483
    .
  17. PMID 28143890
    .
  18. ^
    S2CID 7820105
    .
  19. S2CID 8239162
    .
  20. PMID 26269525
    .
  21. PMID 16603397
    .
  22. PMID 19185849
    .
  23. PMID 22461615
    .
  24. PMID 20860370
    .
  25. PMID 26293922
    .
  26. PMID 26235620
    .
  27. PMID 21659604
    .
  28. PMID 32392211
    .
  29. PMID 25422441
    .
  30. PMID 22307628
    .
  31. PMID 25196701
    .
  32. PMID 21806543
    .
  33. PMID 22609986
    .
  34. PMID 28189457
    .
  35. PMID 28600802
    .
  36. PMID 24140020
    .
  37. PMID 30510625
    .
  38. PMID 24631838
    .
  39. PMID 24856037
    .
  40. PMID 29232555
    .
  41. PMID 32472766
    .
  42. PMID 29329306
    .
  43. PMID 23935948
    .
  44. PMID 25162417
    .
  45. PMID 29866702
    .
  46. PMID 22521878
    .
  47. PMID 22773877
    .
  48. PMID 24072782
    .
  49. PMID 25059582
    .
  50. PMID 32720643
    .
  51. PMID 19497867
    .
  52. PMID 20332342
    .
  53. PMID 17967879
    .
  54. PMID 25161886
    .
  55. PMID 27304501
    .
  56. PMID 21266327
    .
  57. PMID 31373126
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=MTORC2&oldid=1216246956"